BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 5563386)

  • 1. [Comparative evaluation of the antiarrhythmic effect of derivatives of diphenylacetic acid and novocaine amide].
    Serdiuk EN; Koval'chuk LA
    Farmakol Toksikol; 1971; 34(2):168-70. PubMed ID: 5563386
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental arrhythmia and its prevention].
    Stazhadze LL; Ventslavskaia TA; Korzhova VV
    Kosm Biol Aviakosm Med; 1985; 19(6):64-8. PubMed ID: 4087865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiarrhythmic effect of oxylidine].
    Zaĭtseva KA; Mashkovskiĭ MD
    Farmakol Toksikol; 1970; 33(3):305-9. PubMed ID: 4393832
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiarrhythimic properties of ethmozine].
    Kaverina NV; Senova ZP; Vikxliàev IuI; Ul'iànova OV
    Farmakol Toksikol; 1970; 33(6):693-7. PubMed ID: 4103389
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative antiarrhythmic and antitoxic activity of beta-hexamethyleneimino-para-butoxypropiophenone, novocaine amide and quinidine in arrhythmia, induced by calcium chlorides in mice].
    Ammar EM
    Farmakol Toksikol; 1968; 31(5):597-601. PubMed ID: 5707735
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antiarrhythmic activity of beta-aminoketones in comparison with quinidine and procaine amide in arrhythmia produced by calcium chloride in mice].
    Iur'ev EG; Iur'eva TI
    Farmakol Toksikol; 1973; 36(1):29-32. PubMed ID: 4685151
    [No Abstract]   [Full Text] [Related]  

  • 8. [A comparative study of the antiarrhythmic action of bonnecor and the mesidide derivatives of alpha-azacycloalkane carboxylic acids].
    Paliani-Katsitadze NSh; Berdiaev SIu; Turilova AI; Kaverina NV; Likhosherstov AM
    Eksp Klin Farmakol; 1994; 57(3):15-7. PubMed ID: 8049618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiarrhythmic properties of fubromegan on different models of experimental cardiac arrhythmia].
    Samvelian VM; L'vov MV
    Farmakol Toksikol; 1970; 33(3):309-13. PubMed ID: 4393833
    [No Abstract]   [Full Text] [Related]  

  • 10. The actions and clinical use of the newer antiarrhythmic drugs.
    Hayes AH
    Ration Drug Ther; 1972 Jul; 6(7):1-6. PubMed ID: 5085124
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide].
    Savina MD; Kudrin AN
    Farmakol Toksikol; 1982; 45(2):63-5. PubMed ID: 7075754
    [No Abstract]   [Full Text] [Related]  

  • 12. [The anti-arrhythmic activity of quinuclidine derivatives].
    Svistov AS; Skorobogatov VI
    Eksp Klin Farmakol; 1994; 57(5):20-1. PubMed ID: 7696896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(5):566-70. PubMed ID: 5364670
    [No Abstract]   [Full Text] [Related]  

  • 14. [Complications in the treatment of paroxysmal arrhythmias with novocaine amide].
    Fomina IG; Khodzhamirova VS; Lidskiĭ PI
    Klin Med (Mosk); 1976 Apr; 54(4):51-5. PubMed ID: 1016370
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanism of action of 1,4 bis (3'-piperidinopropine-1'-yl-1') benzol on the heart].
    Iziumov EG; Slabuka PA; Andrievskaia EK; Kotliarevskii IL
    Farmakol Toksikol; 1971; 34(2):160-3. PubMed ID: 5105578
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study of the activity of anti-arrhythmia agents in calcium chloride-induced arrhythmia in mice].
    Gorbunova VV; Gorbunov NP
    Farmakol Toksikol; 1983; 46(3):48-50. PubMed ID: 6861988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of lithium hydroxybutyrate and lithium chloride on heart rhythm disorders of various origins].
    Galenko-Iaroshevskiĭ PA; Shadurskiĭ KS; Tikhonov AV
    Farmakol Toksikol; 1984; 47(4):54-9. PubMed ID: 6090202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The anti-arrhythmia activity of quinazopyrine].
    Stets VR; Beregovaia EG; Dunaev VV; Storozhuk BG; Favoritov VN; Stoliarchuk AA; Mazur AI
    Farmakol Toksikol; 1990; 53(3):15-7. PubMed ID: 2387373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiarrhythmic properties of afobazole and other 2-mercaptobensimidazole derivatives].
    Turilova AI; Mozhaeva TIa
    Eksp Klin Farmakol; 2010 May; 73(5):8-11. PubMed ID: 20597362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiral 2-amino-1-butanol xanthone derivatives as potential antiarrhythmic and hypotensive agents.
    Librowski T; Czarnecki R; Jastrzebska M
    Acta Pol Pharm; 1999; 56(1):87-90. PubMed ID: 10635353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.